Enza Biotech was awarded 50.000 Euro from the Horizon 2020 SME instrument phase 1 (H2020-SMEINST-1-2014) for the feasibility study “ENBIOSURF” – Enzymatic production of a novel class of nonionic, mild and biobased surfactants. The project has resulted in an updated business plan for the continued commercialisation of the OLMAG technology. 

Enza Biotech is a partner in a four-year academic collaboration, Biostream, which is an industrial – academia collaborative project on “Biotechnical refining of industrial side-streams” financed by Vinnova, Sweden’s Innovation Agency.